Xtant Medical Holdings, Inc.
XTNT
$0.36
-$0.02-6.55%
AMEX
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 109.53M | 121.91M | 133.93M | 133.08M | 127.77M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 109.53M | 121.91M | 133.93M | 133.08M | 127.77M |
| Cost of Revenue | 44.48M | 45.91M | 49.65M | 50.54M | 50.91M |
| Gross Profit | 65.05M | 76.00M | 84.27M | 82.54M | 76.86M |
| SG&A Expenses | 68.32M | 70.61M | 74.89M | 74.03M | 74.60M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 115.02M | 118.61M | 126.64M | 126.74M | 127.74M |
| Operating Income | -5.50M | 3.30M | 7.28M | 6.35M | 28.00K |
| Income Before Tax | -9.24M | 3.91M | 7.00M | 2.26M | -4.27M |
| Income Tax Expenses | 1.90M | 2.08M | 2.03M | 508.00K | 313.00K |
| Earnings from Continuing Operations | -11.14 | 1.83 | 4.97 | 1.75 | -4.58 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -11.14M | 1.83M | 4.97M | 1.75M | -4.58M |
| EBIT | -5.50M | 3.30M | 7.28M | 6.35M | 28.00K |
| EBITDA | -1.47M | 7.98M | 12.51M | 10.90M | 4.49M |
| EPS Basic | -0.08 | 0.01 | 0.04 | 0.02 | -0.03 |
| Normalized Basic EPS | -0.06 | 0.00 | 0.02 | 0.01 | -0.02 |
| EPS Diluted | -0.08 | 0.01 | 0.03 | 0.01 | -0.04 |
| Normalized Diluted EPS | -0.06 | 0.00 | 0.02 | 0.01 | -0.02 |
| Average Basic Shares Outstanding | 559.86M | 558.91M | 557.92M | 576.34M | 571.73M |
| Average Diluted Shares Outstanding | 581.16M | 589.47M | 592.75M | 600.54M | 585.26M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |